StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.55−0.03 (-1.16%)

Close on Nov 13, 2026Market cap $76.66KP/E –Yield –

Neuphoria Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Neuphoria Therapeutics's market cap was $81.47K on Nov 11, 2026, against $59.20K a year earlier. Over the last 5 years it ranged from $14.65K to $344.60K, with a median of $92.73K.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$81.47K+60.3%
2025Dec 31, 2025$50.82K+84.8%
2024Dec 31, 2024$27.50K-59.0%
2023Dec 29, 2023$67.09K-65.5%
2022Dec 30, 2022$194.23K-35.7%
2021Dec 31, 2021$302.11K–

More Neuphoria Therapeutics figures

See a number that looks wrong?